PRESS RELEASE published on 05/07/2024 at 20:00, 2 years 4 months ago INSTALLUX S.A. : Avis de mise à disposition de l'avis de convocation/réunion à l'AG du 11 juin 2024 et du nombre d'actions et de droits de vote Annonce de la mise à disposition de l'avis de convocation/réunion à l'Assemblée Générale Ordinaire et Extraordinaire du 11 juin 2024 et du nombre de droits de vote et d'actions composant le capital social de la société INSTALLUX cotée sur Euronext Growth Paris Euronext Capital Social Assemblée Générale Relations Investisseurs INSTALLUX
PRESS RELEASE published on 05/07/2024 at 19:30, 2 years 4 months ago JCDecaux : Assemblée Générale de JCDecaux SE du 7 mai 2024 L'Assemblée Générale de JCDecaux SE approuve les résolutions et renouvelle les mandats. Détails sur la politique de rémunération et les nominations clés. Chiffres clés de l'entreprise incluant son positionnement mondial Assemblée Générale Nominations Remuneration Chiffres Clés JCDecaux SE
PRESS RELEASE published on 05/07/2024 at 19:30, 2 years 4 months ago JCDecaux : Annual General Meeting of JCDecaux SE of 7 May 2024 JCDecaux SE AGM 2024 approves financial statements, board mandates, auditors, and executive appointments. Key figures: €3,570.0m revenue, global media leader Financial Statements AGM 2024 Board Appointments JCDecaux SE Media Leader
PRESS RELEASE published on 05/07/2024 at 19:29, 2 years 4 months ago Terms of availability of prospectuses GenSight Biologics announces availability of listing prospectus for new shares on Euronext Paris. The prospectus approved by AMF includes universal registration document, securities note, and summary Euronext Paris New Shares AMF Approval GenSight Biologics Listing Prospectus
PRESS RELEASE published on 05/07/2024 at 19:29, 2 years 4 months ago Modalités de mise à disposition de prospectus GenSight Biologics annonce la mise à disposition d'un prospectus pour l'admission d'actions nouvelles sur Euronext Paris. La société spécialisée dans les thérapies géniques pour les maladies neurodégénératives informe sur le processus Euronext Paris Prospectus GenSight Biologics Thérapies Géniques Maladies Neurodégénératives
PRESS RELEASE published on 05/07/2024 at 19:10, 2 years 4 months ago HiPay Group - Fisrt-quarter revenue 2024 HiPay reports 5% revenue growth in Q1 2024, with sustained sales growth and annual expectations confirmed. Payment volume up 3% to 2.2 billion euros Sales Revenue Growth HiPay Payment Volume Annual Expectations
PRESS RELEASE published on 05/07/2024 at 19:10, 2 years 4 months ago Ajustement de la valeur nominale Pharnext SCA annonce une réduction de capital par ajustement de la valeur nominale de ses actions. Alertes sur les financements dilutifs et conseils aux investisseurs Investisseurs Réduction De Capital Financement Dilutif Maladies Neurodégénératives Pharnext SCA
PRESS RELEASE published on 05/07/2024 at 19:00, 2 years 4 months ago Medacta announces the results of today's Annual General Meeting Medacta announces successful approval of all proposals at Annual General Meeting, including distribution of CHF 11.0 million. Dr. Alberto Siccardi re-elected as Chairman of the Board Board Of Directors Annual General Meeting Medacta Dr. Alberto Siccardi CHF 11.0 Million
PRESS RELEASE published on 05/07/2024 at 19:00, 2 years 4 months ago AS PlusPlus Capital Progresses in Restructuring Process – Application for Approval of Restructuring Plan Submitted to Court Following Investor Voting PlusPlus Capital progresses in restructuring process, submits restructuring plan for court approval after investor voting. Approval expected with extensive support from creditors PlusPlus Capital Court Approval Restructuring Process Investor Voting Creditors Support
PRESS RELEASE published on 05/07/2024 at 19:00, 2 years 4 months ago City Innovate Changes Name to Authorium City Innovate, a technology company serving governments, rebrands as Authorium to offer a unified platform for government administration functions from initiation to completion, supporting document-centric processes and services Rebranding Technology Company Authorium Government Administration Document-centric Processes
Published on 09/10/2026 at 15:20, 4 hours 18 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 4 hours 38 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/10/2026 at 14:37, 5 hours 1 minute ago Worksport (NASDAQ:WKSP) Invites Shareholders to September 15 CEO Town Hall
Published on 09/10/2026 at 14:30, 5 hours 8 minutes ago Solitario Resources CEO to Present at HC Wainwright 28th Annual Global Investment Conference
Published on 09/10/2026 at 19:21, 16 minutes ago EQS-Adhoc: IONOS Group SE launches strategic transformation program and strengthens growth foundation
Published on 09/10/2026 at 19:00, 38 minutes ago EQS-Adhoc: 1&1 AG approves transformation and restructuring program for 1&1 Versatel and adjusts its 2026 EBITDA forecast
Published on 09/10/2026 at 18:30, 1 hour 8 minutes ago Colossal Energy Fields Corp. Announces Warren Irwin as Special Advisor and Significant Investor, Strengthening Financial Strategy, Capital Markets Insight and Energy Project Funding Capabilities
Published on 09/10/2026 at 19:30, 8 minutes ago Mise à disposition du Rapport Financier Semestriel 2026
Published on 09/10/2026 at 18:10, 1 hour 28 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026
Published on 09/10/2026 at 17:45, 1 hour 53 minutes ago COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée
Published on 09/10/2026 at 17:42, 1 hour 55 minutes ago Déclaration d'actions et de droits de vote au 31.08.2026